OraPharma Incorporated

OraPharma, Inc., a specialty pharmaceutical company founded in 1996 with an initial focus on the emerging field of oral health care, discovers, develops and commercializes therapeutics for oral health. OraPharma's initial product, ArestinTM, represents a promising therapeutic advance for the adjunct treatment of periodontal disease. Arestin is the first locally administered time-released antibiotic encapsulated in microspheres that effectively kills the germs that cause periodontal disease or periodontitis, a disease that affects more than 50 million people in the U.S. The Company's other technological initiatives, include a compound for the treatment of oral mucositis, an agent for bone and tissue regeneration, a next-generation periodontal therapeutic and a dental trauma preparation.

Contact Details: 732 Louis Drive Warminster PA 18974 United States of America Tel: 215-956-2200 Fax: Email: WWW: www.orapharma.com/

Loading...

Recent Publications by OraPharma Incorporated:
Periodontitis in cardiology--a clinical perspective. The association between ischemic cardiovascular disease and infectious...	28th September, 2005	OraPharma, Inc, Warminster,	J Int Acad Periodontol. 2005 Apr;7(2):49-54.
A post-marketing study of 2805 patients treated for periodontal disease with Arestin. Recent studies have demonstrated the effectiveness of locally delivered...	12th April, 2005	OraPharma, Inc., 732 Louis Drive, Warminster, PA 18974, USA.	J Int Acad Periodontol. 2004 Oct;6(4 Suppl):150-3.
Are cardiac transplant patients more likely to have periodontitis? A case record study. In several large epidemiological studies chronic periodontitis has been...	16th April, 2003	OraPharma	J Int Acad Periodontol. 2002 Jul;4(3):95-100.

BioNews Results for OraPharma Incorporated:
Sinclair Pharma and Orapharma to terminate US distribution agreement	Datamonitor:  Nov 19 2009 12:45AM Matching: orapharma
SINCLAIR PHARMA PLC - Interim Management Statement	SmartBrief:  Nov 19 2009 9:12AM Matching: orapharma
Sinclair Pharma In Talks About New Decapin	Hemscott:  Nov 19 2009 9:08AM Matching: orapharma
Sinclair Pharma and Orapharma mutually agree to terminate US distribution agreement for Decapinol	Bionity.com:  Nov 14 2009 6:29PM Matching: orapharma
Sinclair Pharma : Sinclair Pharma and Oraphar	Investegate:  Nov 12 2009 8:47AM Matching: orapharma
Promote your company here: BioNewsCast - Press Release Distribution	→View more OraPharma Incorporated news.

OraPharma Incorporated Clinical Trials:
Effect of Adjunctive Treatment With Arestin on the Subgingival Microflora in Patients With Moderate to Advanced Periodontitis

OraPharma Incorporated Patents:
US Patent No.	Title
6946118	Formulations for treating or preventing mucositis
6893665	Formulations for treating or preventing mucositis
6683067	Formulations for treating or preventing mucositis
6682348	Dispensing apparatus and cartridge

OraPharma Incorporated (OPHM) Financial information Links from Barchart
OPHM Quote from from Barchart.com
OPHM Chart from from Barchart.com
OPHM Profile from from Barchart.com
OPHM Opinion from from Barchart.com
→View more OraPharma Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 454 times since April 2007, the link to the organisation's website has been followed 73 times

Recent Search Terms used to find this page: OraPharma | orapharma profile | orapharm | orapharm | ORA Pharma | .

Search for more companies in Warminster

Search for more companies in PA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for OraPharma Incorporated